secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jade Biosciences, Inc. (JBIO)
CIK:        0001798749
Form:       8-K
Filed at:   2025-04-09T23:59:59+00:00
Accession:  0001104659-25-033397
Event type: dividend
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aerovate declares special $2.40/share cash dividend ($69.6M total) conditional on Jade Biosciences merger
--------------------------------------------------------------------------------

- Special cash dividend of $69.6M ($2.40/share) declared, payable to holders of record as of April 25, 2025.
- Dividend conditioned on merger with Jade Biosciences closing, expected on or about April 28, 2025.
- Stockholders to vote on merger at special meeting on April 16, 2025; dividend payment date April 29, 2025.
- Dividend expected to be non-taxable return of capital; company has no current or accumulated earnings and profits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1798749/000110465925033397/0001104659-25-033397-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1798749/000110465925033397/tm2511880d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-033397

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer